Table 6.
Baseline finding | Surveillance colonoscopy finding | |
---|---|---|
HRA,a % (n) | SPb ≥10 mm, % (n) | |
No adenoma | 4.8 (116/2396) | 0.7 (18/2396) |
LRAc | 9.7 (96/991) | 0.5 (5/991) |
HRA | 18.2 (11/603) | 1.0 (6/603) |
LRA + SSP | 18.4 (9/49) | 8.2 (4/49) |
HRA + SSP | 46.4 (13/28) | 3.6 (1/28) |
SSA/Pd | 2.9 (3/104) | 9.6 (10/104) |
SP ≥10 mm | 3.1 (2/65) | 12.3 (8/65) |
NOTE. From Anderson et al,41 adapted with permission. Previously unpublished data provided through personal communication with JC Anderson, LF Butterly, CM Robinson, March 14, 2018, with permission.
HRA, high-risk adenoma; LRA, low-risk adenoma; SSA/P, sessile serrated adenoma/polyp.
HRA includes advanced neoplasia or >2 adenomas.
SP includes HP, SP, or TSA.
LRA includes 1–2 adenomas <10 mm in size.
Included TSA in SSA/P group.